CCR9 inhibitors and methods of use thereof

Details for Australian Patent Application No. 2011218661 (hide)

Owner Millennium Pharmaceuticals, Inc.

Inventors Fleming, Paul; Harriman, Geraldine C. B.; Shi, Zhan; Chen, Shaowu

Agent Davies Collison Cave

Pub. Number AU-B-2011218661

Parent 2010201073

Filing date 30 August 2011

Wipo publication date 15 September 2011

Acceptance publication date 5 July 2012

International Classifications

C07C 311/21 Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61K 31/18 - Sulfonamides

A61K 31/381 - having five-membered rings

A61K 31/44 - Non-condensed pyridines

A61K 31/4409 - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/4425 - Pyridinium derivatives, e.g. pralidoxime, pyridostigmine

A61K 31/444

A61P 1/04 Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 Drugs for disorders of the metabolism

A61P 5/14 Drugs for disorders of the endocrine system

A61P 9/00 Drugs for disorders of the cardiovascular system

A61P 9/10 Drugs for disorders of the cardiovascular system

A61P 13/12 Drugs for disorders of the urinary system

A61P 17/00 Drugs for dermatological disorders

A61P 17/04 Drugs for dermatological disorders

A61P 17/06 Drugs for dermatological disorders

A61P 19/02 Drugs for skeletal disorders

A61P 21/00 Drugs for disorders of the muscular or neuromuscular system

A61P 21/04 Drugs for disorders of the muscular or neuromuscular system

A61P 25/28 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/06 Drugs for immunological or allergic disorders

Event Publications

15 September 2011 Application Open to Public Inspection

  Published as AU-B-2011218661

15 September 2011 Complete Application Filed

5 July 2012 Application Accepted

  Published as AU-B-2011218661

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011218662-Phospholipases, nucleic acids encoding them and methods for making and using them

2011218660-Compositions and methods for manipulating levels of antigen-specific antibodies in a mammal